Increasing Brain Gamma Activity Improves Episodic Memory and Restores Cholinergic Dysfunction in Alzheimer's Disease
- PMID: 35607946
- PMCID: PMC9546168
- DOI: 10.1002/ana.26411
Increasing Brain Gamma Activity Improves Episodic Memory and Restores Cholinergic Dysfunction in Alzheimer's Disease
Abstract
Objective: This study aimed to assess whether non-invasive brain stimulation with transcranial alternating current stimulation at gamma-frequency (γ-tACS) applied over the precuneus can improve episodic memory and modulate cholinergic transmission by modulating cerebral rhythms in early Alzheimer's disease (AD).
Methods: In this randomized, double-blind, sham controlled, crossover study, 60 AD patients underwent a clinical and neurophysiological evaluation including assessment of episodic memory and cholinergic transmission pre and post 60 minutes treatment with γ-tACS targeting the precuneus or sham tACS. In a subset of 10 patients, EEG analysis and individualized modelling of electric field distribution were carried out. Predictors to γ-tACS efficacy were evaluated.
Results: We observed a significant improvement in the Rey Auditory Verbal Learning (RAVL) test immediate recall (p < 0.001) and delayed recall scores (p < 0.001) after γ-tACS but not after sham tACS. Face-name associations scores improved with γ-tACS (p < 0.001) but not after sham tACS. Short latency afferent inhibition, an indirect measure of cholinergic transmission, increased only after γ-tACS (p < 0.001). ApoE genotype and baseline cognitive impairment were the best predictors of response to γ-tACS. Clinical improvement correlated with the increase in gamma frequencies in posterior regions and with the amount of predicted electric field distribution in the precuneus.
Interpretation: Precuneus γ-tACS, able to increase γ-power activity on the posterior brain regions, showed a significant improvement of episodic memory performances, along with restoration of intracortical excitability measures of cholinergic transmission. Response to γ-tACS was dependent on genetic factors and disease stage. ANN NEUROL 2022;92:322-334.
Trial registration: ClinicalTrials.gov NCT04842955.
© 2022 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Conflict of interest statement
A.B. and B.B. have pending patent on the use of non‐invasive brain stimulation to increase memory functions in patients with Alzheimer Disease.
Figures


Similar articles
-
Exposure to gamma tACS in Alzheimer's disease: A randomized, double-blind, sham-controlled, crossover, pilot study.Brain Stimul. 2021 May-Jun;14(3):531-540. doi: 10.1016/j.brs.2021.03.007. Epub 2021 Mar 21. Brain Stimul. 2021. PMID: 33762220 Clinical Trial.
-
Alpha tACS Improves Cognition and Modulates Neurotransmission in Dementia with Lewy Bodies.Mov Disord. 2024 Nov;39(11):1993-2003. doi: 10.1002/mds.29969. Epub 2024 Aug 13. Mov Disord. 2024. PMID: 39136447 Clinical Trial.
-
The effects of gamma-tACS on cognitive impairment in multiple sclerosis: A randomized, double-blind, sham-controlled, pilot study.Mult Scler. 2025 May;31(6):728-739. doi: 10.1177/13524585251333575. Epub 2025 Apr 26. Mult Scler. 2025. PMID: 40285586 Clinical Trial.
-
The impact of gamma transcranial alternating current stimulation (tACS) on cognitive and memory processes in patients with mild cognitive impairment or Alzheimer's disease: A literature review.Brain Stimul. 2023 May-Jun;16(3):748-755. doi: 10.1016/j.brs.2023.04.001. Epub 2023 Apr 5. Brain Stimul. 2023. PMID: 37028756 Free PMC article. Review.
-
Gamma oscillation modulation for cognitive impairment: A systematic review.J Alzheimers Dis. 2025 May;105(2):331-350. doi: 10.1177/13872877251328698. Epub 2025 Mar 28. J Alzheimers Dis. 2025. PMID: 40151908
Cited by
-
Virtual neural network-guided optimization of non-invasive brain stimulation in Alzheimer's disease.PLoS Comput Biol. 2024 Jan 17;20(1):e1011164. doi: 10.1371/journal.pcbi.1011164. eCollection 2024 Jan. PLoS Comput Biol. 2024. PMID: 38232116 Free PMC article.
-
Neurocognitive, physiological, and biophysical effects of transcranial alternating current stimulation.Trends Cogn Sci. 2023 Feb;27(2):189-205. doi: 10.1016/j.tics.2022.11.013. Epub 2022 Dec 19. Trends Cogn Sci. 2023. PMID: 36543610 Free PMC article. Review.
-
Rosavin thwarts amyloid-β-induced macromolecular damages and neurotoxicity, exhibiting anti-Alzheimer's disease activity in Wister rat model.Inflammopharmacology. 2024 Apr;32(2):1461-1474. doi: 10.1007/s10787-023-01320-y. Epub 2023 Sep 27. Inflammopharmacology. 2024. PMID: 37758932
-
Surface Versus Penetrative rTMS Stimulation May Be More Effective for AD Patients with Cerebrovascular Disease.Neurosci Insights. 2025 Mar 25;20:26331055251328355. doi: 10.1177/26331055251328355. eCollection 2025. Neurosci Insights. 2025. PMID: 40143889 Free PMC article.
-
Induced neural phase precession through exogenous electric fields.Nat Commun. 2024 Feb 24;15(1):1687. doi: 10.1038/s41467-024-45898-5. Nat Commun. 2024. PMID: 38402188 Free PMC article.
References
-
- FDA Grants Accelerated Approval for Alzheimer's Drug [Internet] . 2021. [cited 2021 Jul 6 ] Available from: https://www.fda.gov/news-events/press-announcements/fda-grants-accelerat...
-
- Koenig T, Prichep L, Dierks T, et al. Decreased EEG synchronization in Alzheimer's disease and mild cognitive impairment [internet]. Neurobiol Aging 2005;26:165–171.[cited 2019 Oct 9 ] Available from:. https://www.sciencedirect.com/science/article/pii/S0197458004001538?via%.... - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous